Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,104,127 papers from all fields of science
Search
Sign In
Create Free Account
Phenacetin-Containing Mixture
Known as:
Analgesic Mixtures Containing Phenacetin
Analgesic mixtures containing phenacetin are no longer available in the United States. These are known to be human carcinogens. (NCI05)
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Paracetamol and analgesic nephropathy: Are you kidneying me?
F. Waddington
,
M. Naunton
,
Jackson Thomas
International Medical Case Reports Journal
2015
Corpus ID: 22988152
Introduction Analgesic nephropathy is a disease resulting from the frequent use of combinations of analgesic medications over…
Expand
Review
2012
Review
2012
Analgesic Nephropathy: A Reassessment of the Role of Phenacetin and Other Analgesics
L. Prescott
Drugs
2012
Corpus ID: 42671478
SummaryThe weight of clinical evidence linking analgesic abuse with chronic renal disease is overwhelming and analgesic…
Expand
2011
2011
Phenacetin and analgesic mixtures containing phenacetin.
Report on carcinogens : carcinogen profiles
2011
Corpus ID: 2563859
Phenacetin was first listed in the First Annual Report on Carcinogens (1980), as reasonably anticipated to be a human carcinogen…
Expand
2004
2004
Phenacetin and analgesic mixtures containing phenacetin.
Report on carcinogens : carcinogen profiles
2004
Corpus ID: 32851234
1978
1978
Analgesic nephropathy: an important cause of chronic renal failure.
J. Cove-Smith
,
M. Knapp
The Quarterly journal of medicine
1978
Corpus ID: 229835
Study of case-notes and autopsy reports of patients with renal disease suggests that analgesic nephropathy is responsible for at…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE